Totaro, Angelo
 Distribuzione geografica
Continente #
EU - Europa 6.166
NA - Nord America 4.279
AS - Asia 3.073
SA - Sud America 538
AF - Africa 86
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 14.164
Nazione #
US - Stati Uniti d'America 4.126
IT - Italia 2.716
DE - Germania 1.401
SG - Singapore 1.393
CN - Cina 695
SE - Svezia 512
BR - Brasile 420
FR - Francia 414
UA - Ucraina 307
VN - Vietnam 295
GB - Regno Unito 214
IN - India 186
IE - Irlanda 121
CA - Canada 96
NL - Olanda 91
ID - Indonesia 90
RU - Federazione Russa 81
HK - Hong Kong 79
FI - Finlandia 78
PL - Polonia 58
BD - Bangladesh 53
JP - Giappone 50
AR - Argentina 48
TR - Turchia 44
MX - Messico 39
ES - Italia 35
CH - Svizzera 31
BE - Belgio 28
IQ - Iraq 26
ZA - Sudafrica 21
PK - Pakistan 19
AT - Austria 17
KR - Corea 17
CO - Colombia 16
CI - Costa d'Avorio 15
EC - Ecuador 14
AZ - Azerbaigian 12
JO - Giordania 12
LT - Lituania 12
MY - Malesia 12
AE - Emirati Arabi Uniti 10
NG - Nigeria 10
PE - Perù 10
PH - Filippine 10
IR - Iran 9
AU - Australia 8
CL - Cile 8
EG - Egitto 8
EU - Europa 8
PY - Paraguay 8
VE - Venezuela 8
MA - Marocco 7
RO - Romania 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
HU - Ungheria 6
LB - Libano 6
KE - Kenya 5
LK - Sri Lanka 5
PT - Portogallo 5
TN - Tunisia 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
SN - Senegal 4
AL - Albania 3
BH - Bahrain 3
DK - Danimarca 3
GR - Grecia 3
IL - Israele 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
BG - Bulgaria 2
BY - Bielorussia 2
CG - Congo 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
JM - Giamaica 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
Totale 14.142
Città #
Singapore 775
Chandler 548
Ashburn 444
San Jose 407
Rome 384
Milan 270
Jacksonville 164
Los Angeles 143
Beijing 142
Dublin 117
Ann Arbor 116
San Mateo 106
Ho Chi Minh City 105
New York 99
Nürnberg 87
Nanjing 83
Lauterbourg 80
Jakarta 79
The Dalles 77
Frankfurt am Main 72
Dearborn 71
Hanoi 71
Munich 69
Hong Kong 68
Florence 67
Hefei 63
Wilmington 63
Woodbridge 61
Nanchang 56
São Paulo 56
Boston 52
Bremen 48
Houston 47
Tokyo 47
Naples 46
Bologna 44
Dallas 44
Moscow 41
Lawrence 39
Bari 38
Chicago 38
Ottawa 37
Verona 32
Redwood City 30
Palermo 28
Paris 26
Turin 26
Council Bluffs 25
Fairfield 25
Hyderabad 25
Seattle 25
Princeton 24
Redmond 24
Kraków 23
Marseille 23
Santa Clara 23
Catania 22
Buffalo 21
Brussels 20
Helsinki 20
Izmir 20
Montreal 20
Orem 20
Toronto 20
Kent 19
Mountain View 19
Da Nang 18
London 18
Stockholm 18
Warsaw 18
Genoa 17
Cattolica 16
New Delhi 16
St Louis 16
Abidjan 15
Belo Horizonte 15
Brooklyn 15
Seoul 15
University Park 15
Atlanta 14
Denver 14
Jiaxing 14
Kunming 14
Augusta 13
Bexley 13
Boardman 13
Cagliari 13
Düsseldorf 13
Hebei 13
Johannesburg 13
Nuremberg 13
Shenyang 13
Amsterdam 12
Baku 12
Brescia 12
Haiphong 12
Madrid 12
Miami 12
Phoenix 11
Tianjin 11
Totale 6.503
Nome #
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.231
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 956
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 920
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 359
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 328
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 325
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 318
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 264
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 251
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 216
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 200
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 185
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 176
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 172
[Overactive bladder syndrome: the social and economic perspective] 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 169
Imaging in prostate cancer diagnosis: present role and future perspectives 167
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 162
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 161
Microbiological follow-up of nosocomial infections in a single urological center 159
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 158
Brachytherapy in men with prostate cancer: update on indications and outcomes 157
Advanced bladder cancer: New agents and new approaches. A review 156
Imaging in prostate cancer staging: present role e future perspectives 156
Imaging of renal cell carcinoma: state of the art and recent advances 155
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 153
Zinner syndrome: Two cases and review of the literature 148
Advanced bladder cancer: New agents and new approaches. A review 147
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 147
Imaging in prostate cancer staging: present role and future perspectives 145
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 144
Circumcision: history, religion and law 142
Inhibition of prostate efferent neurotransmission by amikacin 142
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 142
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 140
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 140
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 139
InTrathecal mORphine, traNsversus Abdominis Plane Block, and tramaDOl Infusion for Catheter-Related Bladder Discomfort in Patients Undergoing Robot-Assisted Laparoscopic Prostatectomy (TORNADO): A Pilot Prospective Controlled Study 137
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 135
Imaging of renal cell carcinoma: state of the art and recent advances 133
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 131
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 131
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 130
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 130
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 129
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 127
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 122
Imaging in prostate cancer diagnosis: present role and future perspectives 121
Management of Iatrogenic Bladder Injury due to Vascular Surgery: Case Report and Literature Review 121
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 120
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study 120
Depiction of periprostatic nerve fibers by means of 1.5 T diffusion tensor imaging 116
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 115
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 114
Imaging of renal cell carcinoma: state of the art and recent advances. 105
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 103
[Doping and urologic tumors] 102
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 100
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 100
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 99
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 97
[Prostatitis syndromes and sporting activities] 97
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 96
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes 96
What can the metaverse do for urology? 94
[Continuing evolution of statistical tests in medical research] 93
ECG-gated CT angiography of the thoracic aorta: the importance of evaluating the coronary arteries 93
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 92
Relationship between Middle Cerebral Artery Pulsatility Index and Delayed Neurocognitive Recovery in Patients undergoing Robot-Assisted Laparoscopic Prostatectomy 90
Circumcision: history, religion and law 90
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 85
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 84
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 82
Bladder tumor markers: A review of the literature 74
Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy 72
In vitro effect of amikacin on rat and human detrusor muscle contraction 67
Markers for Urological Malignancies 63
Imaging in bladder cancer: Present role and future perspectives 59
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 54
Social, economic, and health utility considerations in the treatment of overactive bladder 54
Metastasis to the renal hilum from malignant melanoma of the anterior trunk: An unusual finding 50
Patient-derived organoids in renal cell carcinoma: A review of methodologies and applications 10
Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions 6
A novel comprehensive cancer genome profiling for non-metastatic prostate cancer: study protocol with FPG500 to detect actionable alterations representative of progressive disease 5
Totale 14.329
Categoria #
all - tutte 48.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022852 83 51 43 84 64 37 30 94 66 66 105 129
2022/20231.761 208 202 156 271 114 203 83 147 186 62 73 56
2023/20241.617 96 225 106 149 110 124 112 155 83 138 119 200
2024/20252.175 111 78 187 108 189 86 127 117 267 228 374 303
2025/20264.213 570 119 265 421 765 210 801 227 263 331 152 89
Totale 14.329